Tenofovir is a powerful medicine used to treat infections caused by HIV and Hepatitis B. It works by stopping the virus from copying itself in the body. It's usually taken as part of a combination treatment plan.
Every report comes from a Lived member, sent anonymously.
Have you tried Tenofovir for Hepatitis B?
Tenofovir is an antiviral medicine used against two long-term viral infections: HIV and chronic hepatitis B. It comes in two chemical forms that deliver the same active drug. Tenofovir disoproxil fumarate (TDF), sold as Viread and as generics, is approved for both HIV and chronic hepatitis B in adults and children 2 and older. Tenofovir alafenamide (TAF), sold on its own as Vemlidy, is approved only for chronic hepatitis B in adults and children 6 and older (weighing at least 25 kg) whose liver is still working adequately. For HIV, tenofovir is almost always taken as part of a combination pill rather than by itself. Truvada (emtricitabine with TDF) and Descovy (emtricitabine with TAF) are used with other HIV medicines for treatment, and are also approved as PrEP (pre-exposure prophylaxis), a daily pill that lowers the chance of getting HIV for people who do not have it. Descovy's PrEP approval does not cover people whose risk comes from receptive vaginal sex. Tenofovir is also one of the ingredients in complete one-pill HIV regimens such as Biktarvy.
HIV and hepatitis B both rely on an enzyme called reverse transcriptase to copy their genetic material so they can multiply. Inside cells, tenofovir is converted into an active form that looks like one of the normal building blocks of DNA. The viral enzyme picks it up by mistake, and once it is built into the growing chain, copying stops. Fewer new viruses are made, so the amount of virus in the blood falls. TDF and TAF are both prodrugs, meaning they are inactive packages that the body converts into tenofovir. TAF is designed to release more of the drug inside target cells, so it works at a much smaller dose and leaves less tenofovir circulating in the blood, which is thought to explain its gentler effect on kidney and bone measurements. Tenofovir lowers viral levels but does not remove the virus from the body, so it controls rather than cures either infection.
Tenofovir is taken by mouth once a day. For adults, Viread (TDF) is usually one 300 mg tablet, with or without food; Vemlidy (TAF) is one 25 mg tablet taken with food. The very different milligram amounts reflect the different forms, so the two are not swapped for each other milligram for milligram. Children's doses are based on weight, and Viread also comes as a powder for children who cannot swallow tablets. Combination pills such as Truvada, Descovy and Biktarvy have their own instructions. People with reduced kidney function may need a different schedule: Viread is given less often when kidney function falls below a set level, while Vemlidy needs no change down to quite low kidney function but is not recommended in kidney failure without dialysis. Taking doses every day matters, because missed doses let the virus multiply and can lead to drug resistance. Keep a supply on hand so you do not run out, and do not stop on your own.
Most people tolerate tenofovir well. Nausea, headache, tiredness, stomach discomfort and diarrhea are the most commonly reported effects, and many fade after the first weeks. The effects that matter most build up quietly, which is why routine blood and urine tests are part of treatment. Tenofovir is cleared by the kidneys and can occasionally damage them, including a pattern called Fanconi syndrome, in which the kidney tubules leak substances such as phosphate that the body needs. It can also slightly reduce bone mineral density. Both effects were smaller with TAF than with TDF in hepatitis B trials, although the long-term meaning of the difference is not known. Call your care team promptly if you notice much less urine than usual, new swelling in the feet or ankles, or bone pain or muscle weakness that keeps getting worse. Yellowing of the skin or eyes, dark urine or pain under the right ribs also need prompt contact. Rarely, these medicines cause lactic acidosis, a buildup of acid in the blood; unusual muscle pain, stomach pain with vomiting, fast or difficult breathing, or cold or bluish hands and feet need a call to the care team right away.
Stopping tenofovir can be dangerous for anyone with hepatitis B. The virus can rebound and cause a severe flare of liver inflammation, which in people with cirrhosis (advanced liver scarring) can lead to liver failure. All tenofovir products carry an FDA boxed warning about this. Do not stop or let a prescription lapse without a plan from the prescriber, who will continue checking liver tests for at least several months after treatment ends. This also applies to people with both HIV and hepatitis B who change HIV regimens, and to PrEP users who have hepatitis B. Tenofovir alone is not enough to treat HIV, and using it alone in someone with undiagnosed HIV can let the virus become resistant to it. For that reason, people starting it for hepatitis B are tested for HIV first, and people starting it for HIV or PrEP are tested for hepatitis B. Because the kidneys clear tenofovir, other medicines that strain the kidneys add to the risk. Avoid high doses or combinations of NSAIDs (anti-inflammatory pain relievers such as ibuprofen and naproxen) unless the prescriber agrees; kidney failure has been reported after people on TDF started them. Antivirals such as acyclovir and valacyclovir, and certain intravenous antibiotics, also need attention. Some HIV and hepatitis C medicines raise tenofovir levels. Vemlidy should not be taken with rifampin or related tuberculosis antibiotics, the seizure medicines phenytoin, phenobarbital or oxcarbazepine, or the herbal supplement St. John's wort, which can lower its levels enough to stop it working. Share a full list of medicines and supplements with the prescriber and pharmacist. Data from a large pregnancy registry have not shown an increase in birth defects with TDF, and anyone pregnant or planning pregnancy should review their regimen with the care team.
For hepatitis B, tenofovir steadily lowers the amount of virus in the blood, and liver tests often improve over months. Most people take it for years, sometimes indefinitely, because it suppresses the virus rather than curing the infection, and stopping can let the virus rebound. How long treatment should last is not settled, so the decision is made with the care team. Follow-up visits track viral levels, liver health and kidney function. For HIV, tenofovir-containing regimens aim to bring the virus down to undetectable levels, which protects the immune system and greatly lowers the chance of passing HIV to others. Treatment is lifelong, and blood tests check both the virus and kidney function. For PrEP, protection depends on taking the pill consistently. Taken as directed, PrEP lowers the risk of getting HIV from sex by about 99%, but it is much less effective when doses are missed, and it does not protect against other sexually transmitted infections. PrEP is started only after a negative HIV test and requires an HIV test at least every 3 months, because undetected HIV during PrEP can become resistant to these drugs.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Tenofovir, what you've noticed, or ask the community a question.